Climate Change Is Hitting the Ocean Hard, Increasing Hazards for Hundreds of Millions of People human-wrongs-watch.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from human-wrongs-watch.net Daily Mail and Mail on Sunday newspapers.
A study of 2,000 UK adults surveyed by Asian food brand Itsu found 49 per cent said they had no clue what a nutritious meal include, with two-thirds of people baffled by protein and fibre.
Study reveals blood tests can offer early indicator of severe COVID-19 ANI | Updated: Mar 02, 2021 09:44 IST
Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19patients.
The findings of the study were published in the journal Blood Advances .
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. However, this study focuses on biomarkers that can help predict severe outcomes in COVID-19patients.
Read Time:
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery.
New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. Patients with high levels of these markers were much more like to require care in the intensive care unit, require ventilation, or die due to their COVID-19, said Dr. Hyung Chun, the lead author, an associate professor of medicine in cardiovascular medicine and pathology and director of translational research at the Yale Pulmonary Vascular Disease Program.
E-Mail
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery.
New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.
The findings appear in the Feb. 26 edition of
Blood Advances. Patients with high levels of these markers were much more like to require care in the intensive care unit, require ventilation, or die due to their COVID-19, said Dr. Hyung Chun, the lead author, an associate professor of medicine in cardiovascular medicine and pathology and director of translational research at the Yale Pulmonary Vascular Disease Program.